Ben Jones from McKesson Specialty Health discusses how the affordable care act will affect oncologists.
Ben Jones, Senior Director of Government Relations, McKesson Specialty Health, The US Oncology Network, discusses how the affordable care act will affect oncologists.
Jones speculates that the act will provide both uncertainty and opportunity for community oncologists. In addition to providing coverage for clinical trials for patients that are already insured, the act will potentially cover an additional 30 million individuals that are currently uninsured through state-based exchanges or expanded Medicaid.
Jones hopes the act will allow for early cancer detection and provide patients with care before the disease becomes too aggressive.
Acalabrutinib/Obinutuzumab Shows Improved PFS in Treatment-Naive CLL
April 10th 2024In an interview with Targeted Oncology, Jeff Sharman, MD, discussed the results of the ELEVATE-TN trial of acalabrutinib with or without obinutuzumab at 74.5 months of follow-up among patients with chronic lymphocytic leukemia.
Read More